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A Cdc42/RhoA regulatory circuit downstream
of glycoprotein Ib guides transendothelial platelet
biogenesis
Sebastian Du¨tting1,2, Frederique Gaits-Iacovoni3, David Stegner1, Michael Popp1,2, Adrien Antkowiak3,
Judith M.M. van Eeuwijk1,2, Paquita Nurden1,4, Simon Stritt1,2, Tobias Heib1,2, Katja Aurbach1,2, Oguzhan Angay2,
Deya Cherpokova1,2, Niels Heinz5, Ayesha A. Baig1,2, Maximilian G. Gorelashvili1,2, Frank Gerner1,2,
Katrin G. Heinze2, Jerry Ware6, Georg Krohne7, Zaverio M. Ruggeri8, Alan T. Nurden4, Harald Schulze1,
Ute Modlich5, Irina Pleines1,2, Cord Brakebusch9 & Bernhard Nieswandt1,2
Blood platelets are produced by large bone marrow (BM) precursor cells, megakaryocytes
(MKs), which extend cytoplasmic protrusions (proplatelets) into BM sinusoids. The mole-
cular cues that control MK polarization towards sinusoids and limit transendothelial crossing
to proplatelets remain unknown. Here, we show that the small GTPases Cdc42 and RhoA act
as a regulatory circuit downstream of the MK-speciﬁc mechanoreceptor GPIb to coordinate
polarized transendothelial platelet biogenesis. Functional deﬁciency of either GPIb or Cdc42
impairs transendothelial proplatelet formation. In the absence of RhoA, increased Cdc42
activity and MK hyperpolarization triggers GPIb-dependent transmigration of entire MKs into
BM sinusoids. These ﬁndings position Cdc42 (go-signal) and RhoA (stop-signal) at the
centre of a molecular checkpoint downstream of GPIb that controls transendothelial platelet
biogenesis. Our results may open new avenues for the treatment of platelet production
disorders and help to explain the thrombocytopenia in patients with Bernard–Soulier
syndrome, a bleeding disorder caused by defects in GPIb-IX-V.
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B
lood platelets are anucleated cell fragments derived from
bone marrow (BM) megakaryocytes (MKs) that are
essential for blood clotting. MKs develop from haemato-
poietic stem cells by a complex maturation process, which
includes DNA replication without cell division (endomitosis) and
the formation of a demarcation membrane system (DMS), which
functions as a membrane reservoir for newly formed platelets1,2.
Mature BM MKs are giant, polyploid cells that localize close to
BM sinusoids in order to extend and release long cytoplasmic
protrusions called proplatelets into the sinusoidal lumen,
from which platelets are shed under the inﬂuence of blood
shear forces3–6. The highly controlled process of transendothelial
platelet biogenesis stands in contrast to transendothelial
migration of whole haematopoietic (progenitor) cells during
mobilization and homing7. A current concept incorporates the
idea that the chemokine stromal cell-derived factor-1 triggers
migration of early MKs from the endosteal niche towards BM
sinusoids8,9 and that the lipid mediator sphingosine-1-phosphate
elicits directed proplatelet extension into the circulation10.
However, the molecular mechanisms regulating the trafﬁcking
of MKs and haematopoietic cells within the BM and across the
endothelial barrier are poorly deﬁned.
Rho GTPases are small proteins (20–25 kDa) belonging to the
superfamily of Ras-related proteins which are found in all
eukaryotic cells11. They are best known for regulating cytoskeletal
dynamics in virtually all cell types12. The best-characterized Rho
GTPases are Cdc42, RhoA and Rac1, whose activation is
associated with the formation of ﬁlopodia, stress ﬁbres and
lamellipodia, respectively. We previously reported that transgenic
mice lacking either Cdc42 or RhoA in MKs and platelets exhibit
pronounced macrothrombocytopenia, indicating a distinct role
of these molecules in platelet production13,14. In addition,
Cdc42 deﬁciency led to decreased ﬁlopodia formation of
platelets on von Willebrand factor (vWF), suggesting a unique
role of Cdc42 downstream of the glycoprotein (GP) Ib subunit of
the vWF receptor complex GPIb-IX-V (ref. 13). Bernard–Soulier
syndrome (BSS) is a rare platelet disorder characterized by
macrothrombocytopenia, which is caused by damaging variants
in either of the three genes encoding the GPIba/b or GPIX
subunits of the GPIb-IX-V complex, leading to its absence from,
or dysfunction at the MK and platelet surface15–19. The
mechanisms by which the receptor controls megakaryopoiesis
and platelet production are largely unknown.
Here, we show that lack of either functional GPIb or Cdc42
reduced MK polarization in vitro and impaired MK localization
at sinusoids and transendothelial biogenesis in vivo. In contrast,
absence of RhoA in MKs resulted in increased Cdc42 activity and
GPIb-dependent transendothelial migration of entire MKs into
BM sinusoids. These results reveal that Cdc42 and RhoA act as a
regulatory circuit downstream of GPIba to coordinate MK
polarization and transendothelial platelet biogenesis in vivo.
Results
GPIba signalling controls MK localization. Lack of functional
GPIb-IX-V results in impaired DMS development and distribu-
tion during MK maturation in humans and mice20,21. We
analysed MK localization in the BM of mice lacking GPIba
(Gp1ba / ) by immunostaining of native cryosections of whole
femora (Fig. 1). In wild-type (wt) mice, the majority of MKs was
in close contact to BM sinusoids (61.5±4.7%; Fig. 1a,b). Only
rarely were MKs found within the sinusoidal lumen (0.6±1.4%).
Interestingly, in Gp1ba / mice the number of MKs with
direct contact to sinusoids was signiﬁcantly reduced (48.1±4.0%;
P¼ 0.0002; two-way ANOVA with Bonferroni correction
for multiple comparisons) resulting in an increase in BM
haematopoietic compartment (BMHC)-localized MKs (50.2±6.3%;
P¼ 0.0005; Fig. 1a,b).
In view of the multiple intrinsic defects present in MKs
deﬁcient in GPIba22 or GPIbb23 we turned to a mouse line
expressing a mutant version of GPIba, where the ectodomain of
GPIba is replaced by that of the human interleukin-4 receptor a
(IL-4Ra) (Gp1ba / ;tg, further referred to as Gp1ba-Tg).
In these mice, the BSS-associated macrothrombocytopenia is
ameliorated, but not fully reversed (Supplementary Fig. 1a,b
(refs 21,24)), implying a speciﬁc role for the ectodomain of
GPIba in platelet biogenesis. Strikingly, the BM MK distribution
in Gp1ba-Tg mice and Gp1ba / mice was similar, with a
signiﬁcant decrease in the proportion of MKs with sinusoidal
contact (wt: 67.5±6.4%; Gp1ba-Tg: 49.4%±7.0%; Po0.0001)
and a concomitant increase of BMHC-localized MKs
(wt: 30.3±6.6%; Gp1ba-Tg: 49.0±6.0%; Po0.0001; two-way
ANOVA with Bonferroni correction for multiple comparisons)
(Fig. 2a,c). The role of the GPIba ectodomain for MK localization
was further conﬁrmed by treatment of wt mice with the
monovalent Fab fragment of an antibody directed against the
major ligand (vWF)-binding domain of GPIba (p0p/B-Fab) that
is known not to affect platelet survival in the circulation25. While
GPIba blockade had no effect on total MK numbers in the BM
(Supplementary Fig. 1c), it clearly reduced the fraction of MKs
with direct sinusoidal contact (39.5±4.4%; Po0.0001; two-way
ANOVA with Bonferroni correction for multiple comparisons,
Fig. 2a,c). This was associated with a reduction in peripheral
platelet counts and an increase in platelet size by about one third
(Fig. 2d,e) as compared to wt, similar to that seen in Gp1ba-Tg
mice (Supplementary Fig. 1a,b). Formation of the DMS,
as analysed by transmission electron microscopy (TEM), was
unaltered in MKs of Gp1ba-Tg mice or wt mice after GPIba
blockade (Fig. 2b). Together, these ﬁndings revealed a critical role
for the ectodomain of GPIba in controlling MK localization at
vascular sinusoids, independent of its role in DMS development
and partitioning.
We next sought to get insights into the signalling that triggers
GPIba-dependent MK guidance within the BM. Using mice
lacking Cdc42 in MKs and platelets (Cdc42ﬂ/ﬂ Pf4-cre, further
referred to as Cdc42 / (ref. 13)), we have previously shown
that Cdc42 controls cytoskeletal dynamics downstream of GPIba
in platelets and that its absence in MKs causes marked
macrothrombocytopenia by unknown mechanisms13.
Intriguingly, signiﬁcantly fewer Cdc42 / MKs were in direct
contact with BM sinusoids in line with an increased MK
population in the BMHC (Fig. 2f,g) compared to wt littermate
controls (52.0±3.6 P¼ 0.0002; two-way ANOVA with
Bonferroni correction for multiple comparisons). Importantly,
Cdc42 / MKs displayed only partially reduced membrane
invaginations, indicating that the thrombocytopenia in these mice
was not solely the result of a lack of intracellular membranes
(Fig. 2h). Another key component of the GPIba signalling
machinery is phosphoinositide 3-kinase (PI3K) that has been
shown to play an important role in thrombosis and GPIba-
induced integrin activation26,27. Of note, treatment of wt mice
with the PI3K inhibitor wortmannin reduced the number of MKs
in direct contact with sinusoids compared to the control
(55.0±5.9%, P¼ 0.003; two-way ANOVA with Bonferroni
correction for multiple comparisons) (Supplementary Fig. 2d,e),
whereas it had no effect on DMS development or total MK
numbers in the BM (Supplementary Fig. 2a,b,f).
In neuronal cells, PI3K-mediated establishment of cell polarity
was shown to involve the interplay of GTPases with atypical
protein kinase C (aPKC) isoforms, which form part of the
PAR (‘partitioning defective’) complex28. We observed reduced
sinusoidal localization of MKs in mice lacking the aPKC isoform
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PKCi in MKs/platelets (Supplementary Fig. 3a,b), indicating a
role of the PAR complex and atypical PKCs for PI3K-Cdc42
controlled MK polarization and migration/localization.
Regulation of cell polarization by the PAR complex is
characterized by a profound reorganization of the microtubule
cytoskeleton29. Consistently, we found that microtubule
disruption by nocodazole treatment prevented transmigration
of RhoA-deﬁcient MKs (Supplementary Fig. 3c,d, see below)
similar to Cdc42-deﬁciency.
RhoA negatively regulates GPIb-Cdc42 signalling in MKs.
Rho GTPases integrate phosphoinositide signalling and
cytoskeletal dynamics. This involves a cross-regulation between
Cdc42 and RhoA, which tunes GTPase function in different cell
types30,31. It was recently demonstrated that Cdc42 is important
to polarize the MK DMS towards BM sinusoids32. Moreover,
we have previously shown that mice with MK/platelet-speciﬁc
RhoA-deﬁciency (RhoAﬂ/ﬂ Pf4-cre, further referred to as
RhoA / ) exhibit pronounced macrothrombocytopenia
(Supplementary Fig. 4a,b). This ﬁnding was striking since it was
reported that RhoA negatively regulates proplatelet formation of
human CD34þ derived MKs in vitro33. Supporting this result,
we found that proplatelet formation of RhoA / fetal liver
cell-derived MKs in liquid culture in vitro was comparable to the
wt (Supplementary Fig. 4e (ref. 14)). Taking these observations
together, we hypothesized that the apparent platelet biogenesis
defect in RhoA / mice might be mechanistically linked to
defective control of GPIba-Cdc42 signalling and MK localization
within the BM. Intriguingly, in BM sections of RhoA / mice,
we found a dramatic MK mislocalization with approximately 30%
of the cells being present inside the BM sinusoids (27.9±10%,
Po0.0001; two-way ANOVA with Bonferroni correction for
multiple comparisons; Fig. 3a,b, Supplementary Fig. 4c,d). The
remaining MKs were mostly found in direct contact with
sinusoids (61.2±8.6%, P¼ 0.430; two-way ANOVA with
Bonferroni correction for multiple comparisons), while only a
very minor population was present in the BMHC (10.8±2.3%,
Po0.0001; two-way ANOVA with Bonferroni correction for
multiple comparisons). To analyse the ultrastructure of
intrasinusoidal MKs in the intact BM, we performed TEM on
cross-sections of intact femora (Fig. 3c, Supplementary Fig. 5).
Intrasinusoidal RhoA / MKs showed signs of maturation
including poly-lobulated nuclei. The MKs either contained a large
quantity of cytoplasm with a well-developed membrane system
and a pronounced peripheral zone, or showed signs of ﬂow-
dependent DMS/cytoplasm detachment suggestive of proplatelet
formation. Nevertheless, most MKs remained in contact with
sinusoidal endothelial cells. Of note, DMS formation appeared
mostly unaffected in RhoA / MKs when analysed by TEM on
BM cross-sections (Supplementary Fig. 5c), but we frequently
found intact cells of other lineages (typically granulocytes) within
the MKs cytoplasm (Fig. 3c, Supplementary Fig. 5d), a
phenomenon known as emperipolesis34.
Next, we utilized intravital two-photon microscopy (2PM)
for dynamic visualization of MK localization and proplatelet
formation in the BM of the skull over time. As previously
described4, in wt mice multiple MKs were in direct sinusoidal
contact and eventually released long proplatelets into the vascular
sinus (Fig. 3d–f, Supplementary Movie 1). In sharp contrast,
in RhoA / mice, intravital proplatelet formation was increased
(Supplementary Fig. 6a) and entire MKs (i) transmigrated
from the BM compartment into the vascular sinus (Fig. 3e,
Supplementary Movie 2, Supplementary Fig. 6b), (ii) adhered for
up to 30min (maximal observation period) inside the vascular
lumen (Fig. 3f, Supplementary Movies 3 and 4) or (iii) extended
and eventually released very large proplatelet-like fragments into
the circulation (Supplementary Fig. 6c, Supplementary Movie 5).
Although the pulmonary microvessels represent the ﬁrst
capillary bed that receives circulating blood from the BM35,
we did not observe increased numbers of MKs in the lungs of
RhoA / mice (Supplementary Fig. 6d,e), suggesting that the
intrasinusoidal MKs predominantly fragment in the BM
vasculature or elsewhere in the circulation3. These observations
collectively indicate that RhoA negatively regulates MK guidance/
localization towards BM vascular sinusoids and thereby acts as a
key regulator of proplatelet extension across the endothelial
barrier by providing a stop-signal for MK transmigration.
To assess whether the transmigration of RhoA / MKs was
indeed GPIba-dependent, we blocked the major ligand-binding
site of the receptor in wt and RhoA / mice by injection of p0p/
B-Fab. Strikingly, whereas this treatment did not affect overall
MK numbers in the BM (Supplementary Fig. 7), it reduced the
intrasinusoidal localization of RhoA / MKs by more than
70% (8.2±4.4%, Po0.001; two-way ANOVA with Bonferroni
correction for multiple comparisons, Fig. 4a,d). This was
associated with an increased presence of MKs in direct contact
with BM sinusoids and a decreased percentage of BMHC-
localized MKs compared with wt controls and vehicle-treated
RhoA / mice, respectively (Fig. 4d). In contrast, treatment
with Fab fragments of antibodies directed against the major
platelet integrin aIIbb3 (JON/A (ref. 36)) or GPV (DOM1
(ref. 37)) did neither affect MK localization in the wt
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Figure 1 | GPIba deﬁciency alters MK localization in the BM. (a) Quantiﬁcation of MK localization in the BM reveals less sinusoidal contact (SC)
and increased localization in the BM haematopoietic compartment (BMHC) in Gp1ba / mice (grey) compared to the wild-type (wt, black) (n¼ 5);
intrasinusoidal (intrasin.). (b) Representative confocal images of immunostained BM of wt and Gp1ba / mice. Scale bars, 50mm. MKs, proplatelets and
platelets are shown by CD41 staining in green. Endoglin staining (red) labels vessels. DAPI, blue. Arrowhead indicates MKs in the BM haematopoietic
compartment (BMHC). Bar graphs represent mean±s.d. Two-way ANOVA with Bonferroni correction for multiple comparisons; **Po0.01; *Po0.05.
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(Supplementary Fig. 7b,c), nor was it able to revert the
transendothelial migration of RhoA / MKs, demonstrating a
speciﬁc role for GPIb in these processes. We also generated
RhoA / /Gp1ba-Tg mice, in which we found similar results as
compared to p0p/B-Fab treatment (9.5±4.5% MKs intra-
sinusoidal, Fig. 4b,d). Interestingly, inhibition of PI3K by
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Figure 2 | GPIba ectodomain and Cdc42 regulate MK localization in the BM. (a) Confocal images of immunostained BM and (b) TEM analysis of BM
MKs of wt (left panel), Gp1ba / ;tg (Gp1ba-Tg) (middle panel) and wt mice after treatment with GPIba-blocking monovalent Fab fragments, p0p/B-Fab
(right panel). n¼4 biological replicates. Scale bars, 50mm (a) and 2mm (b). MKs, proplatelets and platelets are shown by GPIX staining in green.
Endoglin staining (red) labels vessels. DAPI, blue. Arrowhead indicates MKs in the BM haematopoietic compartment (BMHC). (c) Quantiﬁcation of MK
localization in the BM reveals less sinusoidal contact (SC) in Gp1ba-Tg (dark grey) and wtmice after GPIba-blockade (light grey) compared to the wt (black)
(n¼ 7, 5 and 10); intrasinusoidal (intrasin.). (d,e) Reduced platelet count (d) and increased platelet size (e) in wt mice after GPIba-blockade (n¼4). (f)
Representative confocal images of immunostained BM of Cdc42 / mice. Scale bar, 50mm. (g) Quantiﬁcation of MK localization in the BM reveals
reduced SC in wt (black) and Cdc42 / (grey) mice (n¼ 10 and 3). (h) TEM analysis of BM MKs of Cdc42 / mice. Scale bar, 2 mm. Bar graphs
represent mean±s.d. (c,g) Two-way ANOVA with Bonferroni correction for multiple comparisons; (d,e) Unpaired two-tailed Student’s t-test; ***Po0.001.
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wortmannin treatment likewise signiﬁcantly reduced the number
of intrasinusoidal MKs in RhoA / mice (12.3±5.2%,
Po0.0001; two-way ANOVA with Bonferroni correction for
multiple comparisons), but did not increase the number of MKs
with direct sinusoidal contact (Supplementary Fig. 2d,e). Total
MK numbers in the BM were unaltered in wortmannin-treated
compared to vehicle-treated RhoA / mice (Supplementary
Fig. 2f) and also their DMS appeared largely unaltered
(Supplementary Fig. 2c).
Together, these data indicate that RhoA may act as a negative
regulator of GPIba-Cdc42-driven MK guidance towards BM
sinusoids and transendothelial migration. To further test this
hypothesis, we generated MK/platelet-speciﬁc RhoA/Cdc42-
double-deﬁcient mice (RhoA/Cdc42ﬂ/ﬂ Pf4-cre, further referred
to as RhoA/Cdc42 / ; Supplementary Figs 8a and 11a–c).
Strikingly, RhoA/Cdc42 / MKs massively accumulated around
vascular sinusoids (82.9±5.9%, P¼ 0.0002; two-way ANOVA
with Bonferroni correction for multiple comparisons, Fig. 4c–e,
Supplementary Movie 6), but failed to transmigrate into
the lumen (3.9±1.8% MKs intrasinusoidal, Fig. 4c,e) or to
efﬁciently form transendothelial proplatelets in vivo (Fig. 4f,g,
Supplementary Movie 6). Consequently, these animals were
severely thrombocytopenic (Supplementary Fig. 8b,c). Of note,
intrasinusoidal localization of RhoA / MKs was not altered by
the concomitant lack of Rac1 (RhoA/Rac1 / ) (Supplementary
Fig. 9a–e), thus indicating a speciﬁc RhoA-Cdc42 crosstalk
downstream of GPIba in this process.
RhoA controls MK polarization by limiting Cdc42 activity.
We next investigated whether a possible crosstalk between
Cdc42 and RhoA regulates MK polarization. Importantly, mature
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Figure 3 | RhoA negatively regulates MK guidance and transmigration. (a) Representative confocal images of immunostained BM of RhoA / mice.
Scale bars, 50mm (left panel); 10mm (right panel). MKs, proplatelets and platelets are shown by GPIX staining in green. Endoglin staining (red) labels
vessels. DAPI, blue. Arrowhead indicates MKs in BMHC, asterisk indicates intrasinusoidal (intrasin.) MKs. (b) Quantiﬁcation of MK localization in the BM
reveals abundant intrasinusoidal localization of RhoA / (grey) MKs compared to the wt (black) (n¼ 9). (c) TEM analysis of RhoA / BM MKs.
Scale bars, 2.5mm. EC, endothelial cell; VS, vascular sinus. Asterisk indicates emperipolesis (n¼ 6 (wt) and 8 (RhoA / )). (d–f) Intravital two-photon
microscopy of wt (d) and RhoA / (e,f) BM MKs in the skull. Arrowhead indicates proplatelet formation, asterisk indicates intrasinusoidal MKs
(n¼ 7 and 6). Scale bars, 50mm. Bar graphs represent mean±s.d. Two-way ANOVA with Bonferroni correction for multiple comparisons; ***Po0.001.
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Cdc42 / and Gp1ba-Tg BM MKs displayed defective DMS
polarization after 4 days of liquid culture in vitro (Fig. 5a–c,f),
whereas increased polarization of not fully mature DMS was
observed in RhoA / MKs (Fig. 5d,g). Strikingly, in vitro
treatment with p0p/B-Fab (anti-GPIb) markedly reduced DMS
polarization in cultures of both wt and RhoA / BM MKs
(Fig. 5e,g), suggesting that the regulatory role of GPIba in this
process depends on intracytoplasmic GPIb-IX-V signalling and
may operate in the absence of an ectopic ligand.
To decipher the underlying mechanism, we took advantage
of lentiviral FRET biosensors derived from the Raichu probe
to monitor Cdc42 activity in the polarized DMS32. Wt MKs
showed a polarized Cdc42 activity at the DMS/F-actin complex,
which was reduced by 68% in Gp1ba-Tg MKs (Fig. 6a,b,d),
demonstrating the importance of controlled Cdc42 activation by
GPIba for correct DMS polarization. Strikingly, polarized Cdc42
activity showed a 2.4-fold increase in the absence of RhoA
(Fig. 6c,d), indicating that RhoA controls DMS and subsequently
MK polarization by limiting Cdc42 activity. In order to determine
how the nucleotide state of Cdc42 and RhoA inﬂuences this
regulation, we utilized single amino acid mutants Cdc42/F28L
and RhoA/F30L known to induce a constitutive exchange of GDP
for GTP, thus resulting in hyperactive GTPases38. To restrict the
expression of these mutants to the megakaryocytic lineage, we
generated BM chimeric mice by transplantation of HSCs after
lentiviral gene transfer, in which proteins were expressed under
transcriptional control of the MK/platelet-speciﬁc human GP6
promoter (Fig. 7a,b)39. Of note, control mice transplanted
with GFP-expressing HSCs showed reduced sinusoidal MK
localization compared with non-irradiated mice (44.3±2.94%,
Fig. 7c,f), indicating that irradiation inﬂuences MK localization.
Compared to GFP-positive control cells, vessel association of
Cdc42/F28L expressing MKs (GFPþ /GPIXþ ) was increased
(57.0±9.0%, Fig. 7c,d,f) and approx. 4% of mutant MKs were
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located inside the BM sinusoids, whereas none were found in
this compartment in control mice (Fig. 7c,d,f). In contrast,
RhoA/F30L expression resulted in a further reduction of MKs in
direct contact with BM sinusoids (30.4±6.4%, Fig. 7c,e,f)
conﬁrming the opposing functions of active Cdc42 (go-signal)
and RhoA (stop-signal) in controlling MK localization and
transendothelial proplatelet formation (Fig. 8).
Discussion
MKs are unique among haematopoietic progenitor cells in that
they normally do not cross the endothelial lining of BM sinusoids,
but extend and release portions of their cytoplasm into the blood
stream by so far unknown mechanisms4,5. We now provide
compelling evidence that this key step of unidirectional
transendothelial proplatelet formation is tightly controlled
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within MKs by a crosstalk of Cdc42 and RhoA and requires a
functional GPIba ectodomain to occur efﬁciently (Fig. 8). Our
data reveal a central antagonistic role of Cdc42 and RhoA in MK
polarization and suggest that absence of RhoA supports locally
increased Cdc42 activity and thereby directs the sites of cell
protrusion. Our ﬁndings also highlight a critical function of
the GPIba ectodomain for efﬁcient MK polarization, Cdc42
activation and thus sinusoidal localization and transendothelial
proplatelet formation of mature MKs. Thus, these data indicate
that MK mislocalization within the BM contributes to the
low platelet counts in BSS patients and may mechanistically
explain the defective transendothelial (pro-) platelet formation by
impaired DMS polarization and Cdc42 activation.
Of note, vWF-deﬁcient humans and mice display normal
platelet counts40, and MK localization in the BM was not
altered in Vwf / mice (Supplementary Fig. 10a,b), which
excludes a major role of this ligand in GPIba-dependent MK
polarization.
Besides the vWF binding site, the p0p/B antibody Fab fragment
also completely blocks thrombin binding to mouse GPIba
(Supplementary Fig. 10c), raising the possibility that this process
might play a role in MK localization/polarization. However, MK
localization in the BM of mice expressing human GPIba with a
mutation (D277N) that abolishes a-thrombin binding41 was
similar to that of mice expressing wt hGPIba (Supplementary
Fig. 10d,e), arguing against a role of thrombin in this process.
Intriguingly, however, in vitro treatment of cultured MKs with
p0p/B-Fab was sufﬁcient to almost completely revert the DMS
hyperpolarization observed in RhoA-deﬁcient MKs. Thus, our
ﬁndings do not indicate that GPIba requires binding of an ectopic
ligand to control MK localization and polarization in the BM.
Rather, our results support the hypothesis that GPIba-mediated
regulation of MK polarization might be a cell intrinsic process,
which can be modulated by altering GPIba signalling through
changing the conformation and/or membrane localization/
clustering of the receptor in response to p0p/B-Fab binding.
In line with this, enhanced endogenous binding of mutant vWF
to GPIba in patients with vWF disease-type 2B results in
giant platelets and thrombocytopenia and was reported to be
associated with dysregulation of the LIM kinase/coﬁlin pathway
in MKs, together with upregulated RhoA signalling42. Thus,
altered GPIb-IX-V-mediated intracellular signalling can lead to
abnormal cytoskeletal signalling and severely abnormal MK
function.
Taken all observations together, our data support a model in
which GPIba controls MK localization and transendothelial
MK migration through intracellular signals, namely through the
regulation of cell polarization via the Rho GTPases RhoA and
Cdc42. While this process presumably involves MK PI3K
function, we cannot rule out that treatment with the PI3K
inhibitor wortmannin also exerts effects on vascular cells. Thus,
deciphering the exact role of PI3K and/or PIs in MK localization
requires further investigation. On the other hand, it is well known
that Cdc42 and PI3K play a central role in establishing
morphological and molecular cell polarity in eukaryotic cells28,29.
In neurons, establishment of cell polarity during axon
speciﬁcation requires PI3K-dependent crosstalk of GTPases
with aPKC isoforms which form part of the PAR complex28.
Consistently, Cdc42-mediated cell polarity in migrating astrocytes
occurs through activation of the aPKC isoform PKCz28,43.
Thus, our observation of reduced sinusoidal localization of
MKs in wortmannin-treated mice and mice deﬁcient in the
aPKC- isoform PKCi is supportive of a role of PI3K signalling for
Cdc42/RhoA-controlled MK polarization and localization.
During the last years, experimental evidence has accumulated
suggesting that MKs possess an intrinsic network involving the
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GPIb-IX-V complex and multiple cytoskeletal proteins including
Filamin A, non-muscle myosin IIa (NMM-IIa), b-tubulin,
a-actinin and Diaphanous Related Formin 1 (DIAPH1) that
control the late stages of MK maturation with defects in
individual proteins all giving rise to macrothrombocytopenia40,44.
Interaction of the cytoplasmic domain of GPIba with Filamin A
provides a major link between the receptor and the MK
cytoskeleton and coordinated expression of GPIba and Filamin
A is required for proper localization of either protein45.
Deﬁciency of Filamin A in MKs was shown to affect DMS
formation46 and results in premature release of large, fragile
platelets in humans and mice47,48. Together with the observation
that polarity in osteoclasts depends on a network involving both
Filamin A and Cdc42 (ref. 49) this points to a critical role of
Filamin A for the transmission of signalling between GPIba
and Cdc42.
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Figure 7 | Activation states of RhoA and Cdc42 have opposing functions in MK localization. (a) Third-generation self-inactivating lentiviral vectors were
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Our data from RhoA-deﬁcient mice clearly exclude that size
restrictions limit MK transmigration through BM sinusoids and
emphasize RhoA as a critical regulator of proplatelet extension
across the endothelial barrier by providing a ‘stop’ signal for MK
polarization and thus transmigration (Fig. 8). In line with this,
it has been described that excessive RhoA activation in
BM-derived macrophages leads to decreased polarization,
motility and cell spreading50. Of note, RhoA-dependent
activation of Rho kinase (ROCK) and NMM-IIa was shown
to negatively regulate proplatelet formation in MKs derived
from CD34þ cells in vitro33. Mutations in the gene encoding
NMM-IIa, MYH9, affect platelet biogenesis in patients with
MYH9-related disorders51. Interestingly, MKs from mice
with MK-restricted NMM-IIa deﬁciency (Myh9 / ) exhibit
increased proplatelet formation in vitro52 and a signiﬁcant
number of MK nuclei was observed in lungs of Myh9 /
animals compared to the wild-type53. However, given the
multiple intrinsic defects present in Myh9 / MKs, further
studies using different experimental approaches will be required
to decipher the role of NMM-IIa in RhoA-induced MK
polarization and platelet biogenesis.
In summary, the herein described Cdc42/RhoA regulatory
circuit downstream of GPIb ensures a tight control of
transendothelial platelet biogenesis in the BM and opens new
avenues to treat both inherited and acquired forms of
thrombocytopenia that are major causes of bleeding in man,
and additionally to modulate in vitro production of platelets in
the ﬁeld of transfusion medicine.
Methods
Mice. All animal experiments, except studies involving BM transplantation,
were carried out in the Institute of Experimental Biomedicine (Wu¨rzburg),
and approved by the district government of Lower Frankonia (Bezirksregierung
Unterfranken). BM transplantation experiments were carried out at the
Paul-Ehrlich-Institute (Langen) and approved by the local ethics committee of
the Lower Saxony State Ofﬁce (according to y15 German animal protection law).
Gp1ba / mice (C57Bl/6 background), Gp1ba / ;Tg (Gp1ba-tg) mice (C57Bl/6
background), where the ectodomain of GPIba is replaced by that of the human
interleukin-4 receptor a (IL-4Ra), and Prkci / mice (C57Bl/6 background) have
been described24,54. MK/platelet-speciﬁc conditional RhoA- and Cdc42-deﬁcient
mice (both mixed C57Bl/6 and SV129 background), carrying the Cre-recombinase
under the platelet factor 4 (Pf4) promoter55, have been described13,14.
RhoA / mice were intercrossed with Gp1ba / ;Tg mice to generate
RhoA / /Gp1ba / ;Tg mice, with Cdc42 / mice to generate RhoA/Cdc42 /
mice, and with Rac1 / mice (mixed C57Bl/6 and SV129 background) to
generate RhoA/Rac1 / mice. Prkci / mice were kindly provided by
Dr Michael Leitges54. Vwf / mice (C57Bl/6 background) were kindly provided
by Dr Cecile Denis56. Mice used in experiments were 8 to 16 weeks old and
sex-matched (both sexes used), if not stated otherwise.
Antibodies and reagents. Anaesthetic drugs (medetomidine (Pﬁzer), midazolam
(Roche) and fentanyl (Janssen-Cilag)) were used according to the regulations of the
district government of Lower Frankonia (Bezirksregierung Unterfranken). Mice
were bled into high-molecular-weight heparin (Ratiopharm). Mice were treated
with the selective PI3K inhibitor wortmannin (Sigma-Aldrich; 1 mg g 1 body
weight; days 1 and 3), the microtubule polymerization inhibitor nocodazole
(Sigma-Aldrich; 10mg g 1 body weight; days 1–3), or with monovalent Fab
fragments of antibodies directed against the major ligand-binding domain of
GPIba (p0p/B-Fab (ref. 25); 100mg per mouse, days 1 and 3), integrin aIIbb3
(JON/A (ref. 36); 100 mg per mouse, days 1–3) or GPV (DOM1 (ref. 37); 100 mg per
mouse, days 1–3). Mice were killed and femora dissected and processed on day 5.
Antibodies were ﬂuorescently labelled using protein labelling kits (Alexa Fluor
488/546/647, Life Technologies). Anti-CD105 antibody (120402 (MJ7/18),
BioLegend) or Tetramethylrhodamine dextran (2MDa; Thermo Scientiﬁc) were
used for BM vasculature staining. All other antibodies were produced and modiﬁed
in our laboratory37. Antibodies were incubated for 6–8 h with immobilized papain
or for 24 h with immobilized pepsin according to the manufacturer’s instructions
(Pierce Biotechnology, Inc.), and the preparations were then applied to an
immobilized protein A column, followed by an immobilized protein G column
(Pharmacia) to remove Fc fragments and undigested IgG. Purity of Fab or F(ab)2
fragments was tested by SDS–PAGE. For control experiments, puriﬁed rat IgG2a
(Serotec) and nonimmune control rat IgG Fab were used.
Immunoﬂuorescence staining on whole femora cryosections. Femora were
isolated, ﬁxed with 4% PFA (AppliChem) and 5mM sucrose (Sigma-Aldrich),
transferred into 10% sucrose in PBS and dehydrated using a graded sucrose series.
Subsequently, the samples were embedded in Cryo-Gel (Leica Biosystems)
and shock frozen in liquid nitrogen. Frozen samples were stored at  80 C.
Seven-micrometer-thick cryosections were generated using the CryoJane tape
transfer system (Leica Biosystems) and probed with Alexa488-conjugated anti-
GPIX antibody, to speciﬁcally label platelets and MKs, and Alexa647-conjugated
anti-CD105 antibodies (3.33mgml 1, 120402 (MJ7/18), Biolegend) to stain the
endothelium. Nuclei were stained using DAPI (4,6-diamidino-2-phenylindole;
1mgml 1, D1306, Invitrogen). Samples were visualized with a Leica TCS SP5
confocal microscope (Leica Microsystems).
TEM of bone marrow megakaryocytes. For TEM of MKs, BM was ﬂushed from
12- to 16-week-old mice using Karnovsky ﬁxative (2% PFA, 2.5% glutaraldehyde
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Figure 8 | Model of the Cdc42/RhoA regulatory circuit controlling
GPIba-dependent platelet biogenesis. (a) Wt BM MKs polarize their DMS
as prerequisite for directed proplatelet release into sinusoidal vessels. This
polarization is driven by locally active Cdc42. (b) Perturbed intracellular
GPIba-signalling reduces local Cdc42 activity and results in defective
DMS polarization, reduced MK localization at BM sinusoids and decreased
transendothelial proplatelet formation. (c) In the absence of RhoA,
Cdc42 activity is locally increased resulting in hyperpolarized MKs entirely
transmigrating through the endothelial barrier into sinusoidal vessels.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15838
10 NATURE COMMUNICATIONS | 8:15838 | DOI: 10.1038/ncomms15838 | www.nature.com/naturecommunications
in 0.1M cacodylate buffer) and incubated overnight at 4 C. Subsequently, fatty
components of the samples were ﬁxed with 2% osmium tetroxide in 50mM sodium
cacodylate (pH 7.2), stained with 0.5% aqueous uranyl acetate, dehydrated with a
graded ethanol series and embedded in Epon 812. Ultra-thin sections were stained
with 2% uranyl acetate (in 100% ethanol) followed by lead citrate. Images were
taken on a Zeiss EM900 TEM (Zeiss). ImageJ software (Wayne Rasband, NIH,
USA: http://rsb.info.nih.gov/ij) was used to quantify DMS.
Two-photon intravital microscopy of the BM. Mice were anaesthetized by
intraperitoneal injection of medetomidine 0.5 mg g 1, midazolam 5 mg g 1 and
fentanyl 0.05 mg g 1 body weight. A 1 cm incision was made along the midline to
expose the frontoparietal skull, while carefully avoiding damage to the bone tissue.
The mouse was placed on a customized metal stage equipped with a stereotactic
holder to immobilize its head. BM vasculature was visualized by injection of
tetramethylrhodamine dextran (8 mg g 1 body weight, 2MDa, Thermo Scientiﬁc).
Platelets and MKs were antibody stained with anti-GPIX-AlexaFluor 488 (i.v.
injection of 0.6 mg g 1 body weight). Images were acquired with a ﬂuorescence
microscope equipped with a  20 water objective with a numerical aperture of 0.95
and a TriM Scope II multiphoton system (LaVision BioTec), controlled by
ImSpector Pro-V380 software (LaVision BioTec). Emission was detected with
HQ535/50-nm and ET605/70-nm ﬁlters. A tunable broad-band Ti:Sa laser
(Chameleon, Coherent) was used at 760 nm to capture Alexa Fluor 488 and
rhodamine dextran ﬂuorescence. ImageJ software (NIH) was used to generate
movies.
Flow cytometry. Diluted blood (1:20) was incubated for 15min at room
temperature (RT) with ﬂuorophore-conjugated antibodies (2 mgml 1) directed
against platelet surface GPs57. Platelet count and size (forward scatter) were
assessed using a FACSCalibur (BD Biosciences) ﬂow cytometer.
Immunoblotting. Denatured platelet lysates were separated by SDS–PAGE and
blotted onto polyvinylidene diﬂuoride membranes. Membranes were incubated
with anti-RhoA antibody (0.5 mgml 1, Cytoskeleton Inc.), anti-Cdc42 antibody
(0.5mgml 1, Cytoskeleton Inc.) or anti-Rac1 antibodies (0.5 mgml 1,
BD Biosciences) antibodies followed by incubation with appropriate horseradish
peroxidase-conjugated secondary antibodies (1 h, room temperature) and
enhanced chemiluminescence solution (JM-K820-500, MoBiTec). Images were
recorded using a MultiImage II FC Light Cabinet (Alpha Innotech Corporation)
device. As loading control, integrin b3 (GPIIIa) levels were determined.
Histology. Three-micrometer-thick sections of formalin-ﬁxed parafﬁn-embedded
spleens and lungs were prepared, deparafﬁnized and stained with haematoxylin
and eosin (MHS32 and 318906, Sigma-Aldrich). MKs were stained with
HRP-labelled anti-GPIba antibodies after antigen retrieval and detected with
3-amino-9-ethylcarbazole substrate. MK number, morphology and localization
were analyzed with an inverted Leica DMI 4,000 B microscope.
In vitro BM MK isolation and differentiation. BM cells were obtained from
femur and tibia by ﬂushing, and lineage depletion (Lin ) was performed using
CD16/CD32þ , Gr1þ , B220þ and CD11bþ antibodies (Biolegend). Lin cells
were cultured in 2.6% nutrient-supplemented StemPro medium with 2mM
L-glutamine, 100 IUml 1 penicillin, 50mgml 1 streptomycin and 20 ngml 1
murine stem cell factor, 15 IUml 1 heparin and 50 ngml 1 of mTPO at 37 C
under 5% CO2 for 3 days. Where indicated, MK cultures were supplemented daily
with 50 mgml 1 of p0p/B-Fab fragment. Mature MKs were enriched by a one-step
BSA gradient.
Analysis of MK polarization. For immunoﬂuorescence, MKs in suspension were
ﬁxed and permeabilized in one step for 30min in PBS with 3.7% formaldehyde and
0.05% Triton X-100. Samples were saturated in 1% fatty acid free BSA in PBS.
Incubation with antibodies, ﬂuorescent secondary antibodies, AlexaFluor-labelled
phalloidin or DAPI was performed for 1 h at RT. For 3D imaging, cells were kept in
m-slide ibiTreat chambers (Ibidi) in PBS. Confocal images were captured with a
LSM780 operated with Zen software using a  63, 1.4 NA Plan Apochromatic
objective lens (Carl Zeiss). Proﬁling of ﬂuorescence intensity was done with ImageJ
(NIH). For 3D-analysis, z-stacks were taken and processed with the Imaris 6.4.2
software (Bitplane AG).
FRET-based measurement of Cdc42 activity. The Raichu-Cdc42 encoding
sequence was ampliﬁed by PCR using Raichu-1054X plasmid as a template and
cloned in frame into the pTRIP-IRES lentiviral vector plasmid using BamHI and
NheI restriction sites (underlined)32. The primers were 50-CGCGGATCCTTGG
CAAGAATTCGGCATGG-3 (forward) and 50-CTAGCTAGCGGCAGAGGGAAA
AAGATCCGTCGAC-30 (reverse). UT711oc1 cells were transduced by incubation
with lentiviral particles at a multiplicity of infection (MOI) of 1 for 2 days.
Transduction efﬁciency was checked by ﬂuorescence and reached about 100% of
the population. Transduction of primary MKs was performed on Lin population
at an MOI of 5 for 1 day, then 50 ngml 1 mTPO were added for 3 additional days.
FRET efﬁciency was represented as the colour-coded ratio image of YFP/CFP after
background subtraction using MetaMorph (Universal Imaging). Acquisitions were
performed with a LSM780 confocal microscope piloted by the Zen software, using a
 63, 1.4 NA Plan Apochromatic lens (Carl Zeiss).
Lentiviral gene transfer of Rho GTPase mutants. The cDNAs of Cdc42F28L or
RhoAF30L were inserted into lentiviral vectors upstream of an IRES co-expressing
eGFP as reporter (lentiviral vector RRL.PPT.SF.eGFP.pre kindly provided by
A. Schambach, Hannover Medical School58). Expression was controlled by the
MK-speciﬁc human GP6 promoter (hGP6,  697 to þ 29 (ref. 59)). Lentiviral
particles were produced by transient transfection in 293T cells. The day before
transfection, 5 106 293T cells were seeded in 10 cm plates in DMEM medium
containing 10% fetal calf serum, 1% glutamine, 1% penicillin/streptomycin,
20mM HEPES. The next day, 293T cells were transfected by calcium-phosphate
transfection method with 10 mg of vector plasmid, 10mg gag/pol plasmid
(pCDA3.GP.4XC plasmid), 1.5 mg plasmid encoding the VSV-G envelope (pMD.G
plasmid), 5 mg Rev encoding plasmid in DMEM medium supplemented with
25 mM of chloroquine. Lentiviral supernatants were collected after 36 and 48 h post
transfection, and concentrated by ultra-speed centrifugation at 80,000 g 2 h.
Concentrated viral particles were resuspended in StemSpan medium (Stem Cell
Technologies, Ko¨ln, Germany) and stored at  80 C. Prior to viral transduction,
Lin BM cells were pre-stimulated for 24–48 h in StemSpan containing
10 ngml 1 murine stem cell factor, 20 ngml 1 murine TPO, 10 ngml 1
recombinant human FGF-1, 20 ngml 1 murine IGF2, 1% penicillin/streptomycin,
2mM glutamine. 5 105 Lin cells were transduced twice on two following days
with lentiviral vectors on Retronectin (Takara-Clontech, 10 mg cm 2) coated wells
(24-well or 12-well plates, dependent on the number of cells for transduction,
with a deﬁned MOI).
BM transplantation. 8–12-week-old female C57Bl/6 mice were preconditioned
with 10Gy irradiation and transplanted with 5 105 cells. Cell infusion was
performed via tail vein injection in a ﬁnal volume of 150 ml. All mice were kept in
the speciﬁed pathogen-free animal facilities of the Paul-Ehrlich-Institute, Langen,
Germany.
Statistical analysis. When comparing two experimental groups, data distribution
was analysed using the Shapiro–Wilk test. Where indicated, statistical signiﬁcance
between two experimental groups was analysed using an unpaired two-tailed
Student’s t-test. Otherwise, data were analysed using two-way analysis of variance
(ANOVA) with Bonferroni correction for multiple comparisons (Prism 7;
GraphPad Software). P-valueso0.05 were considered as statistically signiﬁcant.
*Po0.05; **Po0.01; ***Po0.001 or as otherwise stated. Data are presented as
mean ± s.d.
Data availability. All data generated or analysed during this study are included in
this published article (and its Supplementary Information ﬁles).
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